Genomic landscape of circulating tumor DNA in HER2-low metastatic breast cancer
{{output}}
The large population of HER2-low breast cancer patients necessitates further research to provide enhanced clinical guidance. In this study, we retrospectively analyzed 1071 metastatic breast cancer (MBC) patients and the circulating tumor DNA (ctDNA) to invest... ...
